HART, Radek, Martin KOMZÁK, František OKÁL, David NÁHLÍK, Pavel JAJTNER and Miloš PUSKEILER. Allograft alone versus allograft with bone marrow concentrate for the healing of the instrumented posterolateral lumbar fusion. Spine journal. New York: Elsevier Science, 2014, vol. 14, No 7, p. 1318-1324. ISSN 1529-9430. Available from: https://dx.doi.org/10.1016/j.spinee.2013.12.014.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Allograft alone versus allograft with bone marrow concentrate for the healing of the instrumented posterolateral lumbar fusion
Authors HART, Radek (203 Czech Republic, guarantor, belonging to the institution), Martin KOMZÁK (203 Czech Republic, belonging to the institution), František OKÁL (703 Slovakia), David NÁHLÍK (203 Czech Republic), Pavel JAJTNER (203 Czech Republic) and Miloš PUSKEILER (203 Czech Republic).
Edition Spine journal, New York, Elsevier Science, 2014, 1529-9430.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30211 Orthopaedics
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.426
RIV identification code RIV/00216224:14110/14:00076560
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.spinee.2013.12.014
UT WoS 000338467000034
Keywords in English Lumbar spine; Posterolateral fusion; Allograft; Bone marrow concentrate; Mesenchymal stem cells; Fusion rate
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 23/9/2014 14:18.
Abstract
BACKGROUND CONTEXT: Spondylodesis in the operative management of lumbar spine diseases has been the subject of numerous studies over several decades. The posterolateral fusion (PLF) with pedicle screw fixation is a commonly used procedure. PURPOSE: To determine whether the addition of bone marrow concentrate (BMC) to allograft bone increases fusion rate after instrumented posterior lumbar fusion. STUDY DESIGN: The study was prospective, randomized, controlled, and blinded. METHODS: Eighty patients with degenerative disease of the lumbar spine underwent instrumented lumbar or lumbosacral PLF (22 men, 58 women; body mass index less than 35 for a good visualization of the PLF in the X-rays). In 40 cases, the PLF was done with spongious allograft chips alone (Group I, age 62.7 years in average, range 47-77 years, level of fusion 1-2). In another 40 cases, spongious allograft chips were mixed with BMC (Group II, age 58.5 years in average, range 42-80, level of fusion 1-3), including the mesenchymal stem cells (MSCs). Patients were scheduled for anteroposterior and lateral radiographs 12 and 24 months after the surgery and for computed tomography scanning 24 months after the surgery. Fusion status and the degree of mineralization of the fusion mass were evaluated separately by two radiologists blinded to patient group affiliation. The bony mass was judged as fused if there was uninterrupted bridging of well-mineralized bone between the transverse processes or sacrum, with trabeculation indicating bone maturation on least at one side of the spines. RESULTS: In Group I at 12 months, the bone graft mass was assessed in X-rays as fused in no cases (0%) and at 24 months in four cases (10%). In Group II, 6 cases (15%) achieved fusion at 12 months and 14 cases (35%) at 24 months. The statistically significant difference between both groups was proven for complete fusion at both 12 (p=.041) and 24 months (p=.011). Computed tomography scans showed that 16 cases (40%) in Group I and 32 cases (80%) in Group II had evidence of at least unilateral continuous bridging bone between neighboring vertebrae at 24 months (p<.05). CONCLUSIONS: We have confirmed the hypothesis that the autologous BMC together with the allograft is a better alternative for PLF than the allograft alone. The use of autologous MSCs in form of BMC in combination with allograft is an effective option to enhance the PLF healing.
PrintDisplayed: 22/7/2024 20:15